News

Featured News

  • 2024 |
  • 2023 |
  • 2022 |
  • 2021 |
  • 2020 |
  • 2019 |
  • 2018 |
  • 2017 |
  • View All
  • Press Release | May 28, 2024

    Affini-T Therapeutics Announces First Patient Dosed in KRAS G12V Phase 1 Program and Presentation of Trial-in-Progress Poster at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting

    Read More

    Press Release | April 2, 2024

    Freenome Announces Topline Results for PREEMPT CRC® to Validate the First Version of its Blood-Based Test for the Early Detection of Colorectal Cancer

    Read More

    News | March 25, 2024

    Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million

    Read More

    News | February 21, 2024

    Q32 Bio Announces Publication of Preclinical Data in Molecular Therapy Demonstrating the Therapeutic Potential of Tissue-Targeted Complement Inhibitor ADX-097 for Complement-Mediated Diseases

    Read More

    Press Release | February 15, 2024

    Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection

    Read More

    Press Release | February 8, 2024

    Metagenomi Announces Pricing of Initial Public Offering

    Read More

    Press Release | February 4, 2024

    Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis

    Read More